Background and Objectives: There is a clinical need to assess the resection margins of tongue cancer specimens, intraoperatively. In the current ex vivo study, we evaluated the feasibility of hyperspectral diffuse reflectance imaging (HSI) for distinguishing tumor from the healthy tongue tissue. Study Design/Materials and Methods: Fresh surgical specimens (n = 14) of squamous cell carcinoma of the tongue were scanned with two hyperspectral cameras that cover the visible and near-infrared spectrum (400–1,700 nm). Each pixel of the hyperspectral image represents a measure of the diffuse optical reflectance. A neural network was used for tissue-type prediction of the hyperspectral images of the visual and near-infrared data sets separately as ...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Aim Gastrointestinal (GI) cancers account for 26% of global cancer incidence with prevalence project...
Background and Objectives: There is a clinical need to assess the resection margins of tongue cancer...
\u3cp\u3eThis ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for ...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Aim Gastrointestinal (GI) cancers account for 26% of global cancer incidence with prevalence project...
Background and Objectives: There is a clinical need to assess the resection margins of tongue cancer...
\u3cp\u3eThis ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for ...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
This ex-vivo study evaluates the feasibility of diffuse reflectance spectroscopy (DRS) for discrimin...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Hyperspectral imaging is a promising technique for resection margin assessment during cancer surgery...
Aim Gastrointestinal (GI) cancers account for 26% of global cancer incidence with prevalence project...